Zhao Gang
Professor
College of Chemical Engineering
Sichuan University
China
Biography
Zhao Gang, Professor, Department of Pharmacy and Bioengineering, School of Chemical Engineering, Sichuan University, Ph.D. In 1980 and 1987 , he studied at the Department of Chemistry of Sichuan University and Department of Chemistry, Lanzhou University, and received his Ph.D. degree from the Chinese University of Hong Kong in 1999 . From 1987 to 1996 , he taught at Sichuan University. In 1999 went to France in the French National Center for scientific research in postdoctoral research. In 2000 the United States Ohio State University researcher assistant. Since 2003 , one of the world's top 500 enterprises in the East Electric Group, Department of Biopharmaceuticals as technical director.
Research Interest
Research interests are organic synthesis, organic synthesis methodology, pharmaceutical polymer materials and other fields of research work in recent years in asymmetric organic synthesis, synthesis of ribonucleic acid and deoxyribonucleic acid, metal organic chemistry, coordination chemistry, crystal science, biology and other fields have important results, was in " Nature ", " J. Am. Chem. Soc. ", " Chemistry & Biology ", " Molecular Microbiology ", " Chem. Eur. J. ", " Organic Letters "," Organometallics "
Publications
-
Changxing Liu, Gang Zhao, Jian Liu, Nianchun Ma, Zongyou Chen, David Gough, and Lei Yu, “Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel†J. Controlled Release, 2009, 140(3), 277-283.
-
Xinghe Wang, Gang Zhao, Sang Van, Lei Yu, David Vera, Stephen B. Howell, “Pharmacokinetics and tissue distribution of PGGA-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenograftsâ€, Cancer Chemotherapy and Pharmacology, 2010, 65, 515-526.
-
Zhongling Feng, Gang Zhao, Lei Yu, David Gough, Stephen B. Howell, “Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxaneâ€, Cancer Chemotherapy and Pharmacology, 2010, 65, 923-930.
